Sunrise

Sunrise is a Health Care startup founded in 2015 with a mission to provide simplified solutions for those affected by sleep disorders. The company's slogan, "Sunrise provides affordable, gold-standard quality sleep disorder diagnosis through a 3-gram sensor with clinical results," encapsulates their approach. They have developed a state-of-the-art 3-gram sensor that enables precise diagnosis of sleep conditions by monitoring nighttime brain activity. This innovative technology has been validated by clinical findings and has shown to match the accuracy of in-lab sleep analyses, but at a fraction of the cost. Sunrise recently secured a €5.40M Series A investment on 31 July 2023, with participation from notable investors including the Amazon Alexa Fund and UI Investissement. This investment further validates the potential of Sunrise's disruptive technology in the sleep disorder diagnosis market. In conclusion, Sunrise's innovative approach to addressing the complexities of sleep disorder diagnosis, coupled with their recent successful Series A investment round, positions the company as a compelling player in the healthcare industry and presents an attractive opportunity for potential venture capital investment.